Please login to the form below

pulmonary embolism

This page shows the latest pulmonary embolism news and features for those working in and with pharma, biotech and healthcare.

FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis

The FDA has approved Micro Labs and Mylan’s generics to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF), one of Eliquis’ key indications. ... BMS and Pfizer’s drug is also used to prevent deep

Latest news

Zafgen shares tumble after FDA places hold on diabetes trial

This was abandoned in 2016 after two patients died in a phase 3 trial of the drug after suffering a pulmonary embolism.
Boston Scientific makes $4.2bn play for UK’s BTG

Boston Scientific’s chief executive Michael Mahoney highlighted BTG’s cancer and pulmonary embolism portfolios – which include products to freeze and deliver radiotherapy or drugs to tumours and devices to dissolve
AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib

as pulmonary embolism (PE) or deep vein thrombosis (DVT) and an uncompetitive dose.
FDA panel undermines Lilly and Incyte’s baricitinib hopes

baricitinib’s potential to cause side effects such as pulmonary embolism and venous thromboembolism.
AbbVie’s JAK inhibitor upadacitinib clears another phase III trial

There was a fatality from a stroke in the trial in a patient, plus one case of a pulmonary embolism, although AbbVie said these occurred in at-risk patients.

More from news
Approximately 2 fully matching, plus 47 partially matching documents found.

Latest Intelligence

Modern anticoagulants threaten status quo

embolism in patients with AF and for the prevention of VTE in patients undergoing knee or hip replacement surgery. ... In one phase III trial, idrabiotaparinux sodium was non-inferior to warfarin in preventing the recurrent VTE at three months in

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

The other side of … Crohn’s disease: What patients say is their truth about living with chronic conditions. “I want to believe in my doctor but I feel more comfortable getting my guidance elsewhere.”...
OPEN Health brings the Best of Both Worlds to MAPS EMEA 2020: ...
1000 Voices Survey: The patient voice is key to creating meaningful changes in healthcare; to drive patients to be more actively involved in their care, which leads to better outcomes. So, we went...